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1. Introduction
Identification and classification of somatic O antigens is one of the most commonly 
used  method  for  typing  of  Gram-negative  bacteria.  It  is  based  on  the  serological  and 
immunological detection of differences in the antigenic composition of the cell envelope. The 
immunodominant molecule is the lipopolysaccharide (LPS), specifically the O-side chain. It 
is  made  up  of  oligosaccharide  repeating  units  and  their  structures  vary  according  to  the 
different serogroups. The other main component of the outer membrane, namely the outer 
membrane protein composition, also allows differentiation between Gram-negative species.
 In 1967 Rauss, Ralovich and Vörös described antigenic relationship between Proteus  
(Morganella)  morganii O34  (8662/64)  and  Escherichia  coli O111  based  on  tube 
agglutination.  However,  no detailed information about the lipopolysaccharide composition 
was given. Another cross-reaction was described earlier between E. coli O111 and Salmonella  
Adelaide O35. These two bacteria have important pathogenicity. The  E. coli  O111:K58:B4 
serotype was among the first E. coli strains identified as a cause of infantile diarrhea and it is 
the second most frequently isolated seroptype causing outbreaks of haemorrhagic colitis with 
life threatening haemolytic uremic syndrome (HUS). 
More profound understanding of these cross-reactions may improve the interpretation 
of serodiagnostic tests. Immunochemical studies of LPS are important for substantiation of 
serological cross-reactivity between representatives of different taxa at the molecular level. 
The cross-reactive antibodies recognize identical or similar disaccharide to a tetrasaccharide 
fragment  in  the oligosaccharide repeating units  of  LPS.  While serological  cross-reactivity 
between common pathogens might cause difficulties in differential diagnostics of infections. 
This  phenomenon  can  have  diagnostic  value  if  one  of  the  cross-reacting  species  is  not 
pathogenic and is unlikely to enter the host. Under these conditions, cross-reacting antigens 
obtained from the non-pathogenic strain can be used for the diagnosis of infections caused by 
the pathogenic counterpart. Study of cross-reacting antigens may be considerably beneficial in 
the search for candidate vaccine strains against pathogenic bacteria. 
O  antigenic  cross  reactions  between  Gram-negative  species  due  to  LPS  chemical 
composition have been repeatedly demonstrated over the years. There are only three cases in 
which the O-antigenic structures have been shown to be not only closely related but identical: 
(1) E. coli O111 and S. enterica O35, (2) E. coli O55 and S. enterica O50 and (3) E. coli O157 
and S. enterica O30.
2. Aims of this study
Our aims were:
1. methodological  improvement  of  ELISA for  LPS,  eligible  for  detection  of  minor 
differences between antigens
2. to test the clinical applicability of our new ELISA method
3. purification and identification of the cross-reacting antigens
4. to determine the serological characteristics of  Proteus morganii O34 (8662/64) LPS 
and  to  compare  it  with  cross-reactive  lipopolysaccharides  from  E.  coli O111  and 
Salmonella Adelaide O35
5. structural analysis and comparison of heat stabile, lipopolysaccharide antigens
6. homology analysis of the rfb gene clusters of the studied strains
7. identification of cross-reacting heat labile, protein antigens
8. to analyse possibilities for vaccination 
9. to expand the scope of our experiments to further bacterial genera in order to uncover 
additional serological relationships
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3. Materials and methods
3.1. Bacteria and antigens
Proteus morganii O34 (8662/64) O1, O9 and O43,  Escherichia coli O21, O22, O33, O61, 
O68 and O111,  Salmonella  Urbana O30,  Salmonella Adelaide O35,  Yersinia enterocolitica 
O9, Shigella sonnei: phase I., phase II.  and Re 4350, Bacteroides fragilis strains were used.
Bacteria  were  grown  in  a  fermentor  at  37°C  (Braun  Melsungen-Biostat  U  30, 
Germany). The lipopolysaccharides (LPS) were prepared by phenol-water method from S-
form bacteria, and by phenol-chlorophorm-petrolether method from R-form bacteria. 
Preparation of outer membrane proteins:  Bacteria were cultivated in 2000 ml of 
tryptic soy broth (TSB) with shaking (100 rpm) at 37°C for 24 h, collected by centrifugation 
at 5000 g for 15 min at 4°C, and washed twice with physiological saline. The outer membrane 
proteins (OMP) were extracted by Osborn’s method.
 
3.2. Electrophoresis of antigens
SDS-PAGE was carried out in a Laemmli discontinuous system in a 12% separation gel. The 
gels containing protein samples were stained by Coomassie Brilliant Blue R-250. The gels 
containing LPS samples were transferred to a fixing solution overnight before silver staining 
by the method of Hancock and Poxton. 
3.3. Production of antisera
Bacteria used for immunization were grown on agar medium at 37 °C overnight, washed and 
adjusted in saline to give 1 x 10 8 cfu/ml.  This suspension was boiled at 100 °C for 1 h. New 
Zealand rabbits (mean weight 3 kg) were immunized intravenously with the above bacterial 
suspension.
Rabbit antibodies were raised also against  outer membrane proteins. The extracted 
OMPs  were  separated  by  SDS-PAGE,  blotted  to  nitrocellulose.  The  nitrocellulose  strips 
containing the proper antigens were dried, dissolved in DMSO and mixed 1:1 with complete 
Freund’s  adjuvant.  One  milliliter  of  this  emulsion  was  injected  subcutaneously  into  the 
interscapular region, 1 ml intraperitoneally and 0.5 ml intramuscularly into each rear thigh. 
Booster injection was given 2 weeks later, then monthly, for 4 months. 
3.4. Tube agglutination
Doubling dilutions of antisera in 1 ml physiological saline were tested starting with a dilution 
of 1 in 100. 25 μl of the bacterial suspension (A600=1.2) was added to each tube including a 
control  one  containing  only  saline.  Agglutination  was  read  by  an  agglutinoscope  after 
incubation at 37°C for 24 h, and the endpoint titer was defined as the highest dilution of 
antiserum where agglutination could be detected. 
3.5. Passive haemagglutination:
The  haemagglutination  experiments  were  performed  in  Takátsy  microplates.  Sheep 
erythrocytes were sensitized with LPS (1.5 mg/ml) in a 37 °C-water bath for 1 h. Red blood 
cells were washed three times with physiological saline and used as a 5% suspension added to 
doubling and triplicate serial dilution of sera. Agglutination was recorded after incubation at 
room temperature for 10 h. 
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3.6. Direct ELISA
The technique was originally described by Engvall and Perlmann, and modified by 
Takahashi. To achieve a better applicability for LPS analysis we further modified the method.
Precoating  of  microplates: A solution  (100  µl)  of  poly-L-lysine  (MW.:  260  000) 
(Sigma Chemicals, St. Louis, MO, USA) (10 µg/ml) in 0.01 M phosphate-buffered saline at 
pH  7.2  (PBS)  was  placed  in  polystyrene  microplates  (Nunc  Immunoplate,  Intermed, 
Denmark). The solution was incubated overnight at room temperature.
Binding of LPS: Aliquots of various concentrations of LPS (100 µl) suspended in PBS 
were placed in poly-L-lysine precoated plates and then incubated for 1 h at 37 oC. The plates 
were washed four times with PBS containing 0.05% Tween 20 (T-PBS).
Our methodological modification for blocking the non-specific binding sites: Casein, 
BSA, goat, sheep, pig, bovine, guinea pig, horse sera were used for blocking non-specific 
binding sites. Aliquots of different dilutions of 0.5% casein or BSA or sera (200  µl) were 
placed in each well, incubated for 30 min at 37 oC, and washed four times with T-PBS.
Antisera: A previously pre-titrated optimum dilution of rabbit immune serum (100 µl) 
was added to each well, incubated for 1 h at 37 oC, and washed four times with T-PBS.
Conjugate: Aliquots (100 µl) of a 1/500 dilution of peroxidase conjugated anti-rabbit 
Ig G (goat sera) (Sigma Chemicals, St. Louis, MO, USA) were added to each well, incubated 
for 1 h at 37 oC, and washed four times with T-PBS.
Substrate: The peroxidase substrate solution containing 0.01% o-phenylene diamine 
(Sigma Chemicals, St. Louis, MO, USA) and 0.03% H2O2 (100 µl) was added to each well. 
Reactions were stopped about 10 min later by 4 N H2SO4. The optical density (OD) was read 
at 492 nm in a Titertek Uniscan reader (Flow Laboratories, Helsinki, Finland).
Quality control: The photometer was blanked on air and the wells were read. The OD 
of buffer control was accepted only if it ranged between 0.000 and 0.099. If the value was 
above 0.100, inadequate washing was considered and the experiments were repeated.  The 
difference between the OD value of the positive control and the negative control (IgG off) 
must have been at least 0.800. Only after these quality control criteria had been fulfilled, the 
photometer was blanked on the negative control, and the experiment was evaluated.
Investigations  with  patients’  sera: When  antibody  titres  in  human  sera  were 
investigated  peroxidase  conjugated  anti-human  immunoglobulin  M  (IgM)  and  mixed 
peroxidase conjugated anti-human immunoglobulins IgG, IgM (Sigma Chemicals, St. Louis, 
MO,  USA)  were  used  for  detection  of  anti-lipopolysaccharide  immunoglobulins  from 
examined patients.  The cut-off  level for a positive reaction was determined at 0.3 optical 
density previously calculated as the level three times above the standard deviation of negative 
controls.  Criterion  for  an  enhanced  titer  was  an  optical  density  at  least  twice  above  the 
standard deviation of negative controls. 
3.7. Immunoblot: 
Electrophoretic transfer of LPS and proteins from SDS-PAGE gel to nitrocellulose sheets of a 
0.2 μm pore size (Sigma Chemicals,  St.  Louis,  MO, USA) was performed at  350 mA in 
electro-blotting apparatus (Bio-Rad Laboratories, Richmond, CA, USA) for 60 min at 4°C as 
described by the supplier.
3.8. Thin layer chromatography (TLC) 
TLC plates were running in a Shandon’s chromatography vessel.  Monosaccharide sample 
solution  of  hydrolyzed  LPS  was  chromatografied  in  Cellulose  DC  Plastikfolia  (Merck, 
Darmstadt,  Germany)  thin  layer  with  running  stage:  n-butanol-pyridine-water  (6:4:3)  for 
neutral-, and pyridine-ethyl acetate-water-acetic acid (5:5:3:1) for aminosugars. A mixture of 
D-ribose,  D-mannose,  D-galactose,  D-glucose,  D-heptose,  D-glucosamine  and  D-
galactosamine  (Supelco,  Bellefonte,  PA,  USA)  was  used  as  standard.  The  samples  were 
developed by silver staining described by W. E. Trevelyan et al.
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3.9. Gas chromatography-mass spectrometry (GC-MS)
The sugar composition of  LPS was analyzed after  hydrolysis  of polysaccharide in alditol 
acetate form of monosaccharides. We used an Agilent GC-MS (Agilent technologies, USA) 
gas chromatograph-mass spectrometer system equipped with a 30 m long, internal diameter 
251 µm capillary column Agilent DB-225 HP-1MS (Agilent Technologies, USA), containing 
OV-225 liquid phase. 15 ml/min helium was used as a carrier gas. The temperature was 220 
°C in the injector and 180 °C in the column. As an internal standard we used mesoinozit. 
3.10. Column chromatography
Degradation products of LPS such as polysaccharide (DPS) and Lipid-A were prepared by 
mild acid hydrolysis with 1% acetic acid (100 °C, 90 min). The precipitate was removed by 
centrifugation. The supernatant was fractionated by GPC on column (2.5x80 cm) of Sephadex 
G-50 (Sigma Chemicals, St. Louis, MO, USA) using pyridine-acetic acid buffer to prepare 
purified O-specific polysaccharide and core oligosaccharide.
3.11. NMR
13C-NMR  spectra  were  recorded  with  Varian  UNITYINOVA 400  WB  (100  MHz  for  13C) 
spectrometer.  Measurements  were  run  at  303K  probe  temperature  and  were  made  at 
concentrations of 8 mg/ml in D2O. Acetone was used as internal reference (δC = 31.07 ppm). 
During  the  experiment  46,000  free  induction  decay  signals  (FID’s)  were  acquired. 
Measurements were run with 64,000 datum points using a 30° (2.5µs) pulse and a relaxation 
delay of 3s. Prior to Fourier transformation, the FID’s were multiplied exponentially (using 
3Hz line broadening) and were twice zero-filled.
3.12. Capillary electrophoresis
Capillary  electrophoretic  measurements  were  performed  with  the  Biofocus  3000  system 
(BioRad  Laboratories,  Hercules,  CA,  USA)  applying  “dynamic  sieving”  CE.  Molecular 
weight  of  the  separated  proteins  was  evaluated  by  means  of  the  low  molecular  weight 
calibration kit of Pharmacia. All experiments were repeated three times.
3.13. Lab-on-a-Chip technology
Microchip-based measurements were performed in the commercially available Agilent 2100 
Bioanalyzer  system,  applying  the  Protein  200  Plus  LabChip  Kits.  Chips  were  treated 
according to the protocol provided with the Protein 200 LabChip Kit. 
3.14. Growth inhibition 
Parallel series of serum dilutions were prepared in nutrient broth medium (1 ml) in test tubes. 
To each tube 10 μl of standardized complement (Institute Virion Ltd., Switzerland) and 5 μl of 
bacterial suspension (A600 = 0.6) were added. Absorption was read after incubation at 37 oC for 
24 h. 
3.15. Opsonic function of antibodies
10 μl of each bacterial culture A600 = 0.5 was added to monolayers of RAW264.7 macrophage 
cells.  For  opsonisation bacterial  suspensions  were mixed with a  serum sample of  1:1000 
dilution (complement inactivation by 56°C, 30 min.). After a 30 min uptake, a gentamicin 
solution was added to the medium (final concentration 80 μg/ml) to kill  the extracellular 
bacteria.  Internalized  bacteria  were  enumerated  as  colony-forming  units  by  plating  of 
detergent-lysed (1% Triton X-100 - Sigma Chemicals, St. Louis, MO, USA) macrophages 
onto nutrient agar. 
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3.16. Genetic examination 
The gene cluster  in  O antigen of  E. coli O111 and  S. Adelaide O35 is  well  known and 
accessible in the GeneBank (AF078736, AF285969). Using primers corresponding to  manB 
gene of E. coli we performed PCR amplification and sequential analysis.
 
3.17.  Statistical  analyses  were  performed  using  the  Origin  7.5  graphical  and  statistical 
program (OriginLab Corporation, Northampton MO, USA).
4. Results
4.1.  Methodological  improvement  of  ELISA for LPS,  eligible  for detection  of  minor 
differences between studied antigens
Optimization  of  LPS  concentrations:  Microplates  were  coated  with  various 
concentrations  of  S.  sonnei phase  I  LPS.  Proper  extinction  values  for  evaluation  were 
obtained with LPS concentrations higher than 0.1  µg/ml. For further experiments we used 
LPS concentration at 1 µg/ml.
Optimization of blocking: Microplates were coated with S. sonnei phase I. LPS at 1 µ
g/ml. Non-specific binding sites were saturated with varying dilutions of casein (0.5%), BSA 
(0.5%) or sera of different animal species. Minimum OD background was obtained with a 
serum dilution at 1/20 and a casein and BSA dilution at 1/100 respectively. We used these 
dilutions for further experiments.
Comparison of various blocking agents in ELISA: Casein, BSA, goat, sheep, pig, 
bovine, guinea pig or horse sera were tested. The traditional casein and BSA were compared 
to animal sera. When using goat serum as blocking agent significantly lower OD values were 
measured  for  the  negative  control  (p<0.001)  and  significantly  higher  OD  values  for  the 
positive  control  (p<0.001).  No  statistical  differences  could  be  fined  when comparing  the 
blocking effect of sera originating from different animal species. 
Precision  data:  Intra-assay  variations  were  determined  using  6  simultaneous 
determinations (SD 0.033 for positive controls, and SD 0.023 for negative controls) using 
goat serum in comparison to casein or BSA. Inter-assay variations were determined by testing 
12 determinations performed individually (SD 0.088 for positive controls, and SD 0.097 for 
negative controls) using goat serum in comparison to casein or BSA. 
Reproducibility  of  data:  It  is  well  known that  there  is  an individual  variation in 
protein, immunoglobulin concentration of sera. For excluding the interference of this factor 
with the confidence of our results  we compared goat  sera  from 20 different animals.  No 
significant variation was obtained (SD 0.044 for negative, and 0.080 for positive control).
Competitive re-blocking test:  In simultaneous tests non-specific binding sites were 
blocked, firstly with casein, BSA or goat serum. In the next step, wells blocked with casein or 
BSA were re-blocked with goat serum. Alternatively, wells blocked with goat serum were re-
blocked with casein or BSA. When goat serum was used for re-blocking, the background 
values were significantly lower (p<0.05) than in the case of a simple blocking with either 
casein or BSA. If casein or BSA were used for re-blocking, the background extinctions were 
significantly higher (p<0.05) than for goat serum as the only agent. 
Comparison of various LPS forms: LPS extracted from different smooth and rough 
strains such as S. sonnei phase I and  II, Re 4350, Escherichia coli O21 and O111, Salmonella  
Urbana O30, S. Adelaide O35, Yersinia enterocolitica O9, and Proteus morganii O1, O9 and 
O43 were  used  for  testing the  applicability  of  our  modified  ELISA method.  Goat  serum 
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proved to be the best choice for blocking also in these assays for both smooth and rough 
strains.
Cross reactivity analysis of LPS:  In our experiments antisera to  S. sonnei phase I 
cross reacted with  S. sonnei phase II LPS, but not with  S. sonnei Re 4350 LPS. Antisera 
against  S. sonnei  phase II and  S. sonnei Re 4350 cross reacted with  S. sonnei phase I,  S.  
sonnei phase II,  S. sonnei Re 4350 LPS, too, showing that these antigens contain common 
structural components and are capable to elicit serological cross reaction. The superiority of 
goat serum as blocking agent could be shown also in these experimental settings established 
for studying antigenic relationships between representatives of various bacterial genera.
4.2. Clinical applicability of our modified ELISA method
Using  our  modified  ELISA test  we  investigated  the  possible  relations  between  the 
histological  image  of  the  appendix  and  seroconversion  of  patients  with  appenidicitis  to 
representatives  of  their  intestinal  microbiota.  The  first  serum  was  collected  on  day  of 
operation, the second one 14 days later. Parallel with severity of the inflammation we could 
detect  significantly  higher  antibody levels  in  the patients  when compared  to  the  controls 
(p<0.001 against E. coli, p<0.005 against B. fragilis). 
We could show enhanced antibody titres against the LPS of the anaerobic Bacteroides 
fragilis in most patients with simple and phlegmonous appendicitis. On the other hand for E. 
coli we observed increasing antibody levels parallel to the severity of the inflammation. The 
increasing antibody titres correlated with the time elapsed from the onset of the disease.
The high number of patients with positive serologic test against absolute rough mutant 
LPS of Shigella sonnei Re 4350 (16 from 24 cases) indicates a frequent response to this less 
specific but more common LPS component of Gram-negative bacteria. 
4.3. Purification and identification of cross-reactive antigens 
Preparation of lipopolisaccharides and outer membrane proteins
Extracted and purified lipopolysaccharides were used for further examination in undigested 
form or  after  partial  or  complete  hydrolysis.  Hydrolyzed  compounds  were  purified  with 
column chromatography method. Preparation of bacterial  outer membrane proteins (OMP) 
was carried out as described in Materials and Methods.
4.4. Serological characteristics of Proteus morganii O34 (8662/64) LPS and comparison 
with  cross-reactive  lipopolysaccharides  extracted  from  E.  coli O111  and  Salmonella 
Adelaide O35
Confirmation of serological cross-reaction between the three strains:
Using bacterial  tube agglutination we were able to reproduce the results of cross-
agglutination test carried out by Rauss, Ralovich and Vörös. For proper serological analysis of 
LPS  we  used  purified  LPS  extracted  from  these  bacteria.  The  results  of  passive 
haemagglutination showed several serological differences between strains, but considerable 
cross-reaction as well. The antibodies produced to  P. morganii  O34 showed high reactivity 
with S. Adelaide O35 LPS. No reaction occurred in a reciprocal setting. 
ELISA microplates  were  conjugated  successively  with  LPS,  DPS  and  Lipid-A 
extracted from P. morganii O34, E. coli O111 and S. Adelaide O35 strains and then incubated 
with sera produced against these bacteria. The intensity of reactions with E. coli O111 and S.  
Adelaide O35 LPS seemed similar (OD 1.149-1.361), but with  P. morganii  O34 LPS was 
slightly lower (OD 0.87-1.09) what was perhaps due to its lower DPS content. We could not 
find differences in reactions between P. morganii O34 LPS and different studied sera. E. coli  
O111 and S. Adelaide O35 LPS also gave similar reaction with any cross-reacting sera.  Sera 
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cross-absorbed with whole heat-killed cells (100°C, 60 min.) of these strains was also used. 
For detection of minor antigenic differences and characteristics we used serum dilution too. 
No  differences  between  reactions  were  observed.  So  we  could  detect  serological  cross-
reaction between the three strains by ELISA test using LPS-s and their components.
4.5. Chemical background:
LPS extracts of all  strains gave characteristic silver-stained ladder pattern in  SDS-
PAGE. The profiles of P. morganii O34, E. coli O111, S. Adelaide O35 LPS were similar in 
terms of relative spacing and distribution of bands, as it would be expected if they shared the 
similar O antigen structure and the three profiles could be superimposed. Serological and 
structural similarity between these strains was proved by immunoblotting too. LPS ladders 
of the three strains were revealed also by using P. morganii  O34, E. coli  O111,  S.  Adelaide 
O35 antiserum. The results support the conclusion that the serological cross-reacting structure 
of  these  strains  is  the  O  antigen.  Furthermore,  immunoblotting  with  absorbed  antisera 
provided additional evidence of the involvement of O antigen determinants. 
In the next step monosaccharides obtained with acid hydrolysis were separated by thin 
layer chromatography. We found two spots of neutral sugars at the line of galactose and 
glucose standards. Mannose is absent from each lipopolysaccharide. We couldn’t visualize 
colitose (3,6 dideoxy-L-galactose) because the loss of their -OH radicals confers the ability to 
run more quickly and superpose with glucose.  After calculating the area and intensity of 
glucose and galactose spots we obtained the proportion of glucose (containing colitose) and 
galactose about 3 to 1, namely the proportion of these sugars known in repeating units. In the 
absence of sufficient amount of colitose as standard, we could not detect exactly this rare 
sugar on TLC plate. 
Gas chromatographic spectra for the studied LPS preparations showed similarity of 
their  monosaccharide  contents.  Mass  spectrometric  analysis  of  colitose  (received  as  a 
generous gift from prof. Stefan Oscarson (Stocholm University, Inst. Org. Chem, Sweden) 
was eligible for identification of this rare sugar in our three LPS.
With  13C-NMR spectrometer  we  were  able  to  detect  colitose  in  all  the  three 
lipopolysaccharides studied. The spectrum of DPS polysaccharide prepared from P. morganii 
O34 LPS is similar to spectra from  Escherichia coli O111 and  Salmonella  Adelaide O35, 
however, the determination of fine structure of these LPS-s needs further 13C-NMR analysis. 
4.6. Genetic background 
Preliminary studies in sequence analysis of the manB gene, a representative from the O gene 
cluster showed 70% similarity between P. morganii O34 (8662/64) and S. Adelaide O35, and 
69% similarity between P. morganii O34 (8662/64) and E. coli O111, respectively. We made 
the  P. morganii  O34 (8662/64)  manB gene sequence available in GeneBank with accession 
number EF051576.
4.7. Identification of cross-reacting protein antigens
Capillary electrophoretic OMP profiles
Capillary electrophoretic OMP profiles of the three strains were dominated by the region from 
35 to 50 kDa, and showed close correlation with the microchip based electropherograms. 
Profile of E. coli O111 consisted of more characteristic peaks with three dominating proteins 
of 36, 40, and 45 kDa molecular masses. Pattern of P. morganii O34 (8662/64) revealed two 
characteristic proteins of 36 and 41 kDa. The OMP pattern of S. Adelaide O35 contained more 
major protein peaks, but the presence of the common dominating proteins and the major 39 
kDa protein could be detected in this pattern as well. Quantitative evaluation of protein peaks 
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(peak height and peak areas) was rendered more difficult by the baseline drift observed in 
capillary electrophoretic patterns. 
Chip-based electropherograms of the outer membrane proteins
Microchip-based patterns of all three strains contained the dominating protein peaks in the 35-
50 kDa molecular  weight  range.  In  the  profile  of E.  coli  O111 three  protein peaks  with 
molecular weights of 36, 41, and 45 kDa could be distinquished, the quantity of the 36 kDa 
protein was much higher, than that of the others.  In the same region of  P. morganii O34 
(8662/64) two major OMPs with apparent molecular weights of 36 and 41 kDa, respectively, 
could be detected. The pattern of S. Adelaide O35 was dominated by a protein with molecular 
weight of 39 kD being not present in the patterns of the two other strains. However, the three 
proteins with molecular masses of 36, 41 and 45 kDa could also be detected in the OMP 
profile of S. Adelaide O35. 
The presence of common protein antigens (36 and 41 kDa) in the OMP patterns of the three 
serologically  cross-reacting strains was demonstrated by the simultaneous injection of the 
samples: the peak level of common proteins increased.
SDS-PAGE and Western blot analysis
One-dimensional SDS-PAGE of outer membrane proteins extracted from the analyzed strains 
was performed. The dominating regions containing the major OMPs could be identified by 
this technique as well. The 36 and 41 kDa protein bands were cut out and used to produce 
polyclonal  in  rabbits  to  examine  the  antigenic  relationships.  After  blotting  of  the 
electrophoretically separated outer membrane proteins on nitrocellulose membrane, the sera 
produced against the OMP components of  P. morganii O34 (8662/64),  E. coli  O111 and  S. 
Adelaide O35 strains were applied consecutively against all three strains. The immune sera 
showed high cross-reactivities for all three strains indicating the antigenic relatedness of their 
outer membrane proteins with identical molecular masses.
4.8. Possible applicability of the cross-reactive antigens in vaccine development
Growth inhibition studies: While no significant inhibition of growth occured for the 
three investigated strains in the presence of complement and normal rabbit or human sera, a 
significant restriction of growth occured (p <0.001) when cross-reactive sera and complement 
were added to the cultures of any of the three bacteria. 
In  an  uptake  assay bacterial  uptake  by  RAW264.7  macrophages  significantly 
increased (p<0.001) in the presence of specific or cross-reacting antisera as compared to the 
rate of uptake in the presence of non-specific sera. 
4.9. New possibilities for exploration of other serological cross-reactions
Preliminary results of our ongoing experiments point to further antigenic relationships 
between P.  morganii  O43:12 (Louvain)  -  Y.  enterocolitica O9  -  E.  coli O157:H7 -  S. 
Urbana O30 - Brucella abortus just as between P. morganii O9 (352/56) - E. coli O21;K20 
- S. Inverness O38 - Salmonella O44 - Citrobacter freundi O14 strains. A third antigenically 
related group involves P. morganii O29 (1594) - E. coli O112ac;K68 - S. dysenteriae 2.  As 
severe pathogens occur among these cross-racting bacteria not only a thorough analysis of 
their  antigenic  relations  but  also  the  possibility  of  a  cross-protectivity  is  planned  to  be 
investigated.
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5. Discussion and conclusions
1.-2. ELISA is a sensitive, specific, reproducible and fairly fast method. In case of LPS 
ELISA, problems exist, such as non-specific binding of antibodies to the plastic wells. For 
this reason we aimed to improve the applicability of this method for LPS analysis. Utilizing 
goat  sera  as  blocking  agent  we  could  significantly  decrease  the  background  values  in 
comparison  with  the  originally  and  generally  used  casein  or  BSA.  This  new  blocking 
technique was eligible for detection of minor differences between LPS antigens as shown in 
the case of S. sonnei mutants or cross-reacting bacterial strains as well as in clinical samples.  
3. We were able to reproduce serological cross-reactions described earlier by bacterial 
tube agglutination between strains of various enterobacterial genera. Meticulous examination 
of  these  cross-reaction  was  performed  with  more  sensitive  tests  (e.g.  indirect 
haemagglutinatoin, ELISA, immunoblot). 
4.-5.  Chemical  examination (TLC) of LPS O side chains  detected the presence of 
similar  monosaccharide.  Additionally  the  GC-MS  and  NMR  spectra  of  the  studied 
lipopolysaccharides were similar, and demonstrated that  P. morganii  O34 (8662/64) O side 
chain is made up from the same sugars, and with a similar structure as known in E. coli O111 
and S. Adelaide O35 LPS: namely two colitoses (3,6-dideoxy-L-galactose) linked to glucose, 
galactose and N acetyl-galactosamine.  Our study is the first  report  on the identitiy of the 
monosaccharide composition of the above three bacteria.
 6. Gene sequencing of the manB gene from the O side chain gene cluster shows high 
sequence conservation for the studied bacterial strains.
7. The outer membrane protein components of the three strains were analyzed to prove 
their  significant role in the serological cross reactions.  Expression of a 36 and a 41 kDa 
protein  could  be  detected  in  all  the  three  electropherograms,  and  Western  blot  analysis 
revealed also an antigenic relationship between the corresponding proteins.
8. The results of in vitro bacterial growth inhibitory and macrophage uptake assays 
support the assumption that cross-reactivity might serve as a basis of preventive antibacterial 
methods. 
9. The experiences of this study encourage us to continue our efforts to uncover further 
antigenic relationships for both basic analysis and possible practical applications.
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